Healthy volunteers test new tafamidis tablet against capsule
NCT ID NCT07587697
First seen May 16, 2026 · Last updated Jun 11, 2026 · Updated 5 times
Summary
This study tests whether a new orally disintegrating tablet of tafamidis works the same as the current capsule in healthy adults. Fifteen participants will take single doses of each form under fasting conditions. The goal is to measure drug levels in the blood to confirm the tablet is a suitable alternative.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
P-One Clinic
Hachioji-shi, Tokyo, 1920071, Japan
Conditions
Explore the condition pages connected to this study.